Mettler-Toledo International, Inc. $MTD Stock Sold by Welch & Forbes LLC

Welch & Forbes LLC lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 1.0% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 56,494 shares of the medical instruments supplier’s stock after selling 596 shares during the quarter. Mettler-Toledo International makes up approximately 1.0% of Welch & Forbes LLC’s holdings, making the stock its 29th biggest holding. Welch & Forbes LLC owned about 0.28% of Mettler-Toledo International worth $85,360,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. AlphaCore Capital LLC bought a new position in shares of Mettler-Toledo International in the third quarter worth about $322,000. Fulcrum Asset Management LLP grew its stake in shares of Mettler-Toledo International by 103.1% during the third quarter. Fulcrum Asset Management LLP now owns 6,580 shares of the medical instruments supplier’s stock valued at $10,116,000 after purchasing an additional 3,340 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Mettler-Toledo International by 9.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 951 shares of the medical instruments supplier’s stock valued at $1,409,000 after purchasing an additional 85 shares during the last quarter. Brighton Jones LLC acquired a new stake in shares of Mettler-Toledo International in the third quarter valued at approximately $243,000. Finally, Ethic Inc. increased its holdings in shares of Mettler-Toledo International by 14.5% in the third quarter. Ethic Inc. now owns 2,388 shares of the medical instruments supplier’s stock valued at $3,609,000 after purchasing an additional 303 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International News Roundup

Here are the key news stories impacting Mettler-Toledo International this week:

  • Positive Sentiment: Stifel Nicolaus raised its target from $1,600 to $1,900 and upgraded its rating to “buy,” implying about 7.8% upside. Stifel analyst recommendations
  • Positive Sentiment: Barclays lifted its target from $1,700 to $1,900 and maintained an “overweight” rating, also indicating roughly 7.8% upside. Barclays analyst recommendations
  • Positive Sentiment: Robert W. Baird raised its target from $1,608 to $1,815, while keeping a “neutral” rating; the revised target suggests modest upside. Baird analyst recommendations
  • Neutral Sentiment: JPMorgan raised its target from $1,550 to $1,725 but retained a “neutral” rating; that target is below the quoted share price. JPMorgan analyst recommendations
  • Negative Sentiment: Goldman Sachs increased its target from $1,510 to $1,640, but the new target remains below the quoted share price, suggesting limited near-term upside under its valuation. Goldman Sachs target update

Analysts Set New Price Targets

Several research firms have issued reports on MTD. Royal Bank Of Canada began coverage on Mettler-Toledo International in a report on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price objective on the stock. Wells Fargo & Company lifted their target price on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a research note on Monday, August 3rd. UBS Group assumed coverage on Mettler-Toledo International in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $1,460.00 target price for the company. Rothschild & Co Redburn initiated coverage on Mettler-Toledo International in a research report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 target price for the company. Finally, Barclays upped their price target on Mettler-Toledo International from $1,700.00 to $1,900.00 and gave the company an “overweight” rating in a research note on Monday. Six equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $1,595.77.

Check Out Our Latest Report on MTD

Insider Activity

In other news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the transaction, the chief executive officer owned 4,480 shares in the company, valued at approximately $6,384,000. This trade represents a 17.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.71% of the company’s stock.

Mettler-Toledo International Price Performance

Shares of MTD opened at $1,762.04 on Tuesday. The stock has a 50 day simple moving average of $1,531.95 and a 200 day simple moving average of $1,347.54. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,806.58. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The firm has a market capitalization of $35.31 billion, a PE ratio of 38.40, a P/E/G ratio of 3.47 and a beta of 1.16.

Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $12.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $12.13 by $0.44. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%. The firm had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the business posted $11.15 EPS. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. Sell-side analysts predict that Mettler-Toledo International, Inc. will post 47.49 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.

The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.

Recommended Stories

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.